Medizinische Hochschule Hannover (MHH) / Hannover Medical School

University / College


Location: Hannover, Germany (DE) DE

ISNI: 0000000095299877

ROR: https://ror.org/00f2yqf98

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Long-term outcomes of anti-CD19 CAR T cell therapy in refractory myasthenia gravis: A case series (2026) Hegelmaier T, Motte J, Walther D, Feist E, Duscha A, Desel C, Pappa V, et al. Journal article Comparative evaluation of disease activity measures for adult-onset Still's disease: a multicentre, retrospective, cohort study (2026) Vordenbäumen S, Filla T, Friedrich R, Blank N, Ernst D, Henes J, Keyßer G, et al. Journal article Evidence- and Consensus-based European Guideline for Immunosuppressive Therapy After Pediatric Kidney Transplantation (2026) Grünewald A, Ahlenstiel-Grunow T, Arslan Z, Battelino N, Rachisan ALB, Bouts A, Busutti M, et al. Journal article Toward standardized care: International expert survey on pregnancy management in long-chain fatty acid oxidation disorders and unmet needs (2026) Zeyer KA, Derks TG, Langeveld M, Murphy E, Rossi A, Spiekerkoetter U, Wagenmakers M, et al. Journal article Stratification of children with myocarditis using radiomics signatures in LGE cardiovascular MRI (2026) Laube AP, Huellebrand M, Ter-Minassian L, Uden T, Schwarzkopf E, Opgen-Rhein B, Anderheiden F, et al. Journal article Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis (2026) Kind B, Pham C, Heinrich L, Honstein T, Heratizadeh A, Harder I, Stölzl D, et al. Journal article Improvement of Depressive and Fatigue Symptoms under Dupilumab Therapy in Atopic Dermatitis Patients: Results from the TREATgermany Registry (2026) Traidl S, Cornelius A, Heinrich L, Siegels D, Zacharias H, Heratizadeh A, Honstein T, et al. Journal article Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review (2026) Ahrens M, Haanen J, Albiges L, Goupil MG, Boleti E, Gravis G, Fléchon A, et al. Journal article Nivolumab in combination with lenvatinib in unresectable hepatocellular carcinoma: The IKF-t006/IMMUNIB translational phase-2 study (2026) Vogel A, Ben Khaled N, Ramirez JR, Marhenke S, Siegler G, Siebler J, Lindig U, et al. Journal article Cytokine-mediated activation of kidney-infiltrating CD8⁺ T cells enables their contribution to inflammation in human lupus nephritis (2026) Skopnik CM, Klocke J, Freund P, Metzke D, Ostendorf L, Bunse M, Prskalo L, et al. Journal article